Jul 6, 2026 12:40PM
May 28, 2026 12:00PM
May 26, 2026 12:00PM
May 21, 2026 01:24PM
May 21, 2026 01:24PM
Apr 29, 2026 07:39AM
Apr 27, 2026 07:05AM Seaport Therapeutics appoints Dr. Sharon Mates to board of directors
Apr 27, 2026 07:05AM
Apr 27, 2026 07:00AM
Apr 27, 2026 07:00AM
Apr 22, 2026 12:43PM
Apr 21, 2026 12:30PM
Apr 16, 2026 12:00PM
Mar 26, 2026 01:00PM EIB Waives its Right to Cash Settlement on Medincell Warrants
Mar 6, 2026 02:01AM
Mar 6, 2026 02:00AM
Mar 5, 2026 11:35AM
Mar 5, 2026 11:35AM
Mar 4, 2026 12:00PM
Feb 24, 2026 12:00PM
Feb 20, 2026 03:37PM Medincell: U.S. Food and Drug Administration (FDA) Accepts Teva’s New Drug Application (NDA) for Olanzapine Extended-Release Injectable Suspension (TEV-'749) for the Once-Monthly Treatment of Schizo
Feb 10, 2026 12:00PM
Jan 28, 2026 08:04AM
Jan 20, 2026 12:00PM
Jan 12, 2026 12:00PM
Dec 9, 2025 12:02PM
Dec 9, 2025 08:50AM
Dec 1, 2025 12:00PM Medincell: Videoconference and Publication of Half-year Financial Results, Tuesday, December 9, 2025
Nov 27, 2025 12:00PM
Nov 24, 2025 12:00PM
Nov 13, 2025 12:00PM
Nov 10, 2025 12:00PM
Nov 6, 2025 12:25PM
Nov 5, 2025 07:46AM
Oct 22, 2025 12:00PM Medincell to Participate in the 2025 Truist Securities Biopharma Symposium (New-York)
Oct 10, 2025 04:11PM
Oct 10, 2025 04:11PM
Oct 10, 2025 03:00PM
Oct 10, 2025 03:00PM
Sep 23, 2025 12:00PM
Sep 22, 2025 01:39AM
Sep 22, 2025 01:30AM Medincell: New Pivotal Phase 3 Long-Term Data Supports Olanzapine Long-Acting Injectable (LAI) with Favorable Safety Profile – No PDSS Observed
Sep 22, 2025 01:30AM
Sep 17, 2025 08:01AM
Sep 17, 2025 08:00AM
Sep 5, 2025 12:00PM
Sep 3, 2025 12:00PM
Aug 4, 2025 08:00AM
Jul 30, 2025 07:42AM UZEDY® Accelerates: 2025 Revenue Outlook Raised to $190–$200M (from ~$160M); Olanzapine LAI on Track for Submission in 2025
Jul 30, 2025 05:38AM

324,879 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All